EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Virion proteomics of genetically intact HCMV reveals a regulator of envelope glycoprotein composition that protects against humoral immunity

Kirsten Bentley iD, Evelina Statkute, Isa Murrell, Ceri A Fielding iD, Robin Antrobus, Hannah Preston, Lauren Kerr-Jones iD, Daniel Cochrane, Ilija Brizic iD, Paul J Lehner iD, Gavin W G Wilkinson iD, Eddie C Y Wang iD und 3 weitere

Proceedings of the National Academy of Sciences · 2025

DOI: 10.1073/pnas.2425622122 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2025. Verfasst von Kirsten Bentley und 14 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infection and Immunity, School of Medicine, Cardiff CF14 4XN, United Kingdom. Hauptthemen laut MEDLINE: Cytomegalovirus, Viral Envelope Proteins, Virion, Immunity, Humoral. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: UKRI | Medical Research Council (MRC), NIAID NIH HHS, Wellcome Trust.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Human cytomegalovirus (HCMV) is a clinically important herpesvirus that has coevolved for millions of years with its human host, and establishes lifelong persistent infection. A substantial proportion of its 235 kb genome is dedicated to manipulating host immunity through targeting antiviral host proteins for degradation or relocalization. Quantitative proteomics of the infected cell has extensively characterized these processes, but the cell-free virion has been less well studied. We therefore carried out proteomic analysis of a clinical HCMV strain (Merlin) virion. This revealed 18 novel components, including the viral protein gpUL141, which is recognized as an NK immune-evasin that targets several host proteins (CD155, CD112, and TRAILR) when expressed within the cell. Coimmunoprecipitation of gpUL141 from virions identified interactions with viral entry glycoproteins from the trimer (gH/gL/gO), pentamer (gH/gL/UL128/UL130/UL131A), and gH/gpUL116 complexes, as well as gB. Only interactions with gH/gB occurred in the absence of other viral proteins. Analysis supported a model in which gpUL141 homodimers independently interacted with separate gB/gH-containing complexes. gpUL141 encodes an ER retention domain that restricts trafficking through the ER/Golgi, and limited the transport of glycoprotein complexes bound by gpUL141. As a result, gpUL141 reduced levels of multiple glycoprotein complexes on the infected cell surface as well as in the virion. This reduced syncytium formation, inhibited antibody-dependent cellular cytotoxicity (ADCC), and reduced susceptibility to neutralizing antibodies. Thus, gpUL141 represents an immune-evasin that not only targets host proteins to limit NK-cell attack, but also alters the trafficking of multiple viral glycoprotein complexes in order to evade humoral immunity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CytomegalovirusViral Envelope ProteinsVirionImmunity, HumoralHumansProteomicsCytomegalovirus Infections

Stichwörter der Autor:innen

ADCCHCMVentryglycoproteinsproteomics

Substanzen

Viral Envelope Proteins

Autor:innen und Institutionen

  • Division of Infection and Immunity, School of Medicine, Cardiff CF14 4XN, United Kingdom.
  • Cambridge University Institute for Medical Research, Cambridge University, Cambridge CB2 0XY, United Kingdom.
  • Center for Proteomics, School of Medicine, University of Rijeka, Rijeka 51000, Croatia.
  • Cambridge Institute for Therapeutic Immunology and Infectious Disease, Cambridge University, Cambridge CB2 0AW, United Kingdom.
  • Department of Pathology, University of Cambridge, Cambridge CB2 1QP, United Kingdom.

ORCID-Profile: Kirsten Bentley, Ceri A Fielding, Lauren Kerr-Jones, Ilija Brizic, Paul J Lehner, Gavin W G Wilkinson, Eddie C Y Wang, Stephen C Graham, Michael P Weekes, Richard J Stanton

Förderung

  • UKRI | Medical Research Council (MRC)
  • NIAID NIH HHS
  • Wellcome Trust

Zitieren

APA

Bentley, K., Statkute, E., Murrell, I., Fielding, C. A., Antrobus, R., Preston, H., Kerr-Jones, L., Cochrane, D., Brizic, I., Lehner, P. J., Wilkinson, G. W. G., Wang, E. C. Y., Graham, S. C., Weekes, M. P., & Stanton, R. J. (2025). Virion proteomics of genetically intact HCMV reveals a regulator of envelope glycoprotein composition that protects against humoral immunity. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2425622122

Vancouver

Bentley K, Statkute E, Murrell I, Fielding CA, Antrobus R, Preston H, et al. Virion proteomics of genetically intact HCMV reveals a regulator of envelope glycoprotein composition that protects against humoral immunity. Proceedings of the National Academy of Sciences. 2025. doi:10.1073/pnas.2425622122

BibTeX
@article{Bentley2025,
  author = {Bentley, Kirsten and Statkute, Evelina and Murrell, Isa and Fielding, Ceri A and Antrobus, Robin and Preston, Hannah and Kerr-Jones, Lauren and Cochrane, Daniel and Brizic, Ilija and Lehner, Paul J and Wilkinson, Gavin W G and Wang, Eddie C Y and Graham, Stephen C and Weekes, Michael P and Stanton, Richard J},
  title = {Virion proteomics of genetically intact HCMV reveals a regulator of envelope glycoprotein composition that protects against humoral immunity},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2025},
  doi = {10.1073/pnas.2425622122}
}
Kostenlos starten →